Tag: DETOUR

DETOUR I two-year outcomes: “Excellent” functional improvement in complex PAD cohort

During a late-breaking data session at this year’s Vascular Interventional Advances annual meeting (VIVA 2020; 6–8 November, virtual), Ehrin Armstrong (University of Colorado, Denver,...

PQ Bypass receives IDE approval to initiate pivotal DETOUR II clinical...

PQ Bypass has received conditional approval of its investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to initiate the pivotal...